
Feature|Articles|October 6, 2026
- Nutritional Outlook Vol. 29., No. 9
- Volume 29
- Issue 9
What Long-Term Product Stewardship Looks Like in the Supplement Industry
Author(s)Kim Biedermann, PhD
Why responsible innovation means asking whether yesterday’s formulations still reflect today’s best science—not just launching the next new ingredient.
Advertisement
Advertisement
Science doesn’t stand still, and neither should product innovation. The supplement industry has never had greater access to scientific discovery. New ingredient technologies, advances in novel biological targets and bioavailability and growing consumer demand for personalization are rapidly reshaping the category. At the same time, expectations for evidence, transparency and efficacy have never been higher.
Related to this article

A 4-week trial of 3.5 g of Solnul resistant potato starch increased Bifidobacterium and normal stools versus placebo.

A look at HMOs research, FDA oversight, and claims scrutiny as developments expand in the infant formula category.

From gut-focused longevity to bitterness blocking, dsm-firmenich’s Julia Duchastel and Kathleen McNamara share what’s new at SupplySide Global and what’s ahead for 2027.

At SupplySide Global, Kriti Chaudhary explains how nutraceutical brands can turn clinical research into a price premium and a claim that holds up.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Komal Baldwa, founder and CEO of aspurus about the company’s life-stage optimized dosing platform for women’s health.

At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.

At SupplySide Global, Filipa Quintela shares Kemin’s 2027 outlook, from GLP-1 nutrition science to gut health and longevity, plus how FloraGLO Lutein is moving into cognitive health.
Advertisement
Advertisement

